What is the best stock to buy right now?

2
264
which stock to buy right now? what
which stock to buy right now? what

Our pick as of now for the best stock is : Eli-Lilly ( LLY ) ( Health care sector ) Current price value for Eli-lilly ( 328 USD ) we see 10% more upside in coming months. With average price target 335 USD.

What is the best stock to buy right now ?

Why Eli-Lilly ?

It has top Buy rating from well-known analysts:

ANALYST NAMEPOSITIONPRICE TARGETACTIONDATEARTICLE
Terence FlynnMorgan StanleyBuy395.00Reiterated08.07.22 Read article
Carter GouldBarclaysBuy355.00Reiterated07.07.22 Read article
David RisingerSVB SecuritiesBuy341.00Reiterated30.06.22 
Analyst rating

Eli-lilly has possitive outlook from top hedge fund mangers.

HEDGE FUND ACTIVITIES on Eli-Lilly

MANAGER NAMEHEDGE FUND NAMEACTIONHOLDING CHANGEHOLDING VALUE
Theofanis KolokotronesPRIMECAP Management CoReduced-2.75% 8268.43M
Ken FisherFisher Asset Management LLCAdded7.47% 2148.98M

Philippe Zaouati
Mirova US LLCAdded8.55% 226.61M
Hedge fund activities on Eli-Lilly

What insiders ( management at Eli-lilly ) doing right now?

INSIDER TRANSACTIONS on Eli-Lilly

INSIDER NAMEPOSITION AT LLYTRANSACTIONAMOUNTDATE
Mary Lynne HedleyDirectorUninformative Buy9,97519.07.22
JOHNSON KIMBERLY HDirectorUninformative Buy9,65319.07.22

Erik Fyrwald
DirectorUninformative Buy9,97519.07.22
Insider activities on Eli-Lilly

Dividend payment by Eli-Lilly

Dividend yield for Eli-lilly stock is 1.15% ( 3.79 USD ) Which is modest.

Future pipelines and innovation information for Eli-Lilly:

New phase 3 trials planned for tirzepatide in obesity outcomes, sleep apnea, and renal disease, and releases fresh biomarker data in support of donanemab effectiveness. Pirtobrutinib is being used to treat mantle cell lymphoma.

With COVID-19 therapies excluded, Lilly anticipates 2022 revenue to be in the range of $27.8 billion and $28.3 billion, driven by key growth products that account for two-thirds of core business revenue. Lilly also anticipates operating margins of about 30% on a reported basis and about 32% on a non-GAAP basis, as well as earnings per share (EPS) in the range of $8.00 to $8.15 on a reported basis and $8.50 to $8.65 on

Do also checkout our chart section.

and follow us on twitter , we post daily.